These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 9262087)

  • 21. Detection of scalene lymph node metastases from lung cancer. Positron emission tomography.
    Scott WJ; Gobar LS; Hauser LG; Sunderland JJ; Dewan NA; Sugimoto JT
    Chest; 1995 Apr; 107(4):1174-6. PubMed ID: 7705136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endobronchial ultrasound-guided transbronchial needle aspiration of hilar and mediastinal lymph nodes detected on 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
    Minami D; Takigawa N; Oda N; Ninomiya T; Kubo T; Ohashi K; Sato A; Hotta K; Tabata M; Kaji M; Tanimoto M; Kiura K
    Jpn J Clin Oncol; 2016 Jun; 46(6):529-33. PubMed ID: 27004902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET.
    Gupta NC; Maloof J; Gunel E
    J Nucl Med; 1996 Jun; 37(6):943-8. PubMed ID: 8683316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Test performance of PET-CT for mediastinal lymph node staging of pulmonary carcinoid tumours.
    Pattenden HA; Leung M; Beddow E; Dusmet M; Nicholson AG; Shackcloth M; Mohamed S; Darr A; Naidu B; Iyer S; Marchbank A; Greenwood A; West D; Granato F; Kirk A; Ariyaratnam P; Loubani M; Lim E;
    Thorax; 2015 Apr; 70(4):379-81. PubMed ID: 25124060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma?
    Sivrikoz CM; Ak I; Simsek FS; Döner E; Dündar E
    Thorac Cardiovasc Surg; 2012 Mar; 60(2):116-21. PubMed ID: 21692019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
    Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
    Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling.
    McLoud TC; Bourgouin PM; Greenberg RW; Kosiuk JP; Templeton PA; Shepard JA; Moore EH; Wain JC; Mathisen DJ; Grillo HC
    Radiology; 1992 Feb; 182(2):319-23. PubMed ID: 1732943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advantages of positron emission tomography over computed tomography in mediastinal staging of non-small cell lung cancer.
    von Haag DW; Follette DM; Roberts PF; Shelton D; Segel LD; Taylor TM
    J Surg Res; 2002 Apr; 103(2):160-4. PubMed ID: 11922730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of occult mediastinal node involvement in cN0 non-small-cell lung cancer patients after negative uptake of positron emission tomography/computer tomography scan.
    Gómez-Caro A; Garcia S; Reguart N; Arguis P; Sanchez M; Gimferrer JM; Marrades R; Lomeña F
    Eur J Cardiothorac Surg; 2010 May; 37(5):1168-74. PubMed ID: 20116273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography.
    Erasmus JJ; Patz EF; McAdams HP; Murray JG; Herndon J; Coleman RE; Goodman PC
    AJR Am J Roentgenol; 1997 May; 168(5):1357-60. PubMed ID: 9129444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of positron emission tomography in initial staging of nonsmall cell lung carcinoma: a regional teaching hospital experience.
    Geraldson CT; Stephenson JE; Lagrew JP; Schammel CM; Schammel DP; Greene RA; Bolton WD
    Am Surg; 2012 Mar; 78(3):305-8. PubMed ID: 22524768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thoracic CT scanning in the staging of bronchogenic carcinoma.
    Richey HM; Matthews JI; Helsel RA; Cable H
    Chest; 1984 Feb; 85(2):218-21. PubMed ID: 6319088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images.
    Nomori H; Watanabe K; Ohtsuka T; Naruke T; Suemasu K; Uno K
    Lung Cancer; 2004 Jul; 45(1):19-27. PubMed ID: 15196730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose.
    Patz EF; Lowe VJ; Hoffman JM; Paine SS; Harris LK; Goodman PC
    Radiology; 1994 May; 191(2):379-82. PubMed ID: 8153309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
    Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ
    AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positron emission tomographic imaging with fluorodeoxyglucose isefficacious in evaluating malignant pulmonary disease.
    Graeber GM; Gupta NC; Murray GF
    J Thorac Cardiovasc Surg; 1999 Apr; 117(4):719-27. PubMed ID: 10096967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of integrated positron emission tomography and computed tomography accuracy in detecting lymph node metastasis in patients with adenocarcinoma vs squamous cell carcinoma.
    Billè A; Okiror L; Skanjeti A; Errico L; Arena V; Penna D; Ardissone F; Pelosi E
    Eur J Cardiothorac Surg; 2013 Mar; 43(3):574-9. PubMed ID: 22689182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mediastinal lymph node staging by means of positron emission tomography is less sensitive in elderly patients with non-small-cell lung cancer.
    Al-Sarraf N; Gately K; Lucey J; Wilson L; McGovern E; Young V
    Clin Lung Cancer; 2008 Jan; 9(1):39-43. PubMed ID: 18282357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
    Daniels CE; Lowe VJ; Aubry MC; Allen MS; Jett JR
    Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
    Shim SS; Lee KS; Kim BT; Chung MJ; Lee EJ; Han J; Choi JY; Kwon OJ; Shim YM; Kim S
    Radiology; 2005 Sep; 236(3):1011-9. PubMed ID: 16014441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.